Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Claude Linassier"'
Autor:
Emmanuel Chamorey, Marc Pujalte-Martin, Jean-Marc Ferrero, Hakim Mahammedi, Gwenaelle Gravis, Guilhem Roubaud, Philippe Beuzeboc, Remy Largillier, Delphine Borchiellini, Claude Linassier, Hélène Bouges, Marie-Christine Etienne-Grimaldi, Renaud Schiappa, Jocelyn Gal, Gérard Milano
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 11, p 6058 (2024)
This ABIGENE pharmacokinetic (PK) study sought mainly to characterize the unchanged drug PK during long-term abiraterone acetate (AA) administration in advanced prostate cancer patients (81 patients). It was observed that individual AA concentrations
Externí odkaz:
https://doaj.org/article/05f6059fdd8d425d82f509feeaf79b51
Autor:
Jean-Marc Ferrero, Hakim Mahammedi, Gwenaelle Gravis, Guilhem Roubaud, Philippe Beuzeboc, Remi Largillier, Delphine Borchiellini, Claude Linassier, Nathalie Ebran, Tanguy Pace-Loscos, Marie-Christine Etienne-Grimaldi, Renaud Schiappa, Jocelyn Gal, Gérard Milano
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 651 (2023)
Abiraterone acetate (AA) is the first-in-class of drugs belonging to the second-generation of agents inhibiting androgen neosynthesis in advanced prostate cancer. A cumulative experience attests that germinal gene polymorphisms may play a role in the
Externí odkaz:
https://doaj.org/article/c04920b18f914032b1945806680881d4
Publikováno v:
Innovations & Thérapeutiques en Oncologie. 9:1-8
Autor:
Valentina Orlando, Damien Drubay, Pernelle Lavaud, Laura Faivre, François Lesaunier, Remy Delva, Gwenaëlle Gravis, Frédéric Rolland, Frank Priou, Jean-Marc Ferrero, Nadine Houede, Loic Mourey, Christine Theodore, Ivan Krakowski, Jean-François Berdah, Marjorie Baciuchka, Brigitte Laguerre, Aude Fléchon, Marine Grosse-Goupil, Isabelle Cojean-Zelek, Stéphane Oudard, Jean-Luc Labourey, Paule Chinet-Charrot, Eric Legouffe, Jean-Léon Lagrange, Claude Linassier, Gaël Deplanque, Philippe Beuzeboc, Jean-Louis Davin, Anne-Laure Martin, Meryem Brihoum, Stéphane Culine, Gwénaël Le Teuff, Karim Fizazi
Publikováno v:
Clinical Genitourinary Cancer.
Autor:
Stéphane Oudard, Dominique Helley, Virginie Verkarre, Anne-Sophie Gille, Gérard Milano, Eric Tartour, Abel Grine, Laurence Albiges, Alain Ravaud, Christine Théodore, Claude Linassier, Sylvestre Le Moulec, Stéphane Culine, Sophie Abadie-Lacourtoisie, Armelle Caty, Emeline Levionnois, Marie-Christine Etienne-Grimaldi, Helena Pereira, Laure Fournier, Arnaud Mejean, Laetitia Mauge
Purpose: The PREINSUT study characterized factors predictive of response to sunitinib given before planned nephrectomy in patients with metastatic renal cell carcinoma (mRCC).Patients and Methods: This French multicenter, prospective, open-label, pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::053b088c36432258b9c62fda61e73dd6
https://doi.org/10.1158/1078-0432.c.6527268
https://doi.org/10.1158/1078-0432.c.6527268
Autor:
Stéphane Oudard, Dominique Helley, Virginie Verkarre, Anne-Sophie Gille, Gérard Milano, Eric Tartour, Abel Grine, Laurence Albiges, Alain Ravaud, Christine Théodore, Claude Linassier, Sylvestre Le Moulec, Stéphane Culine, Sophie Abadie-Lacourtoisie, Armelle Caty, Emeline Levionnois, Marie-Christine Etienne-Grimaldi, Helena Pereira, Laure Fournier, Arnaud Mejean, Laetitia Mauge
Summary of currently available data looking at biomarkers during antiantiogenic therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3df73d94b6e31bd18e91f1e56ef05434
https://doi.org/10.1158/1078-0432.22469460.v1
https://doi.org/10.1158/1078-0432.22469460.v1
Autor:
Stéphane Oudard, Dominique Helley, Virginie Verkarre, Anne-Sophie Gille, Gérard Milano, Eric Tartour, Abel Grine, Laurence Albiges, Alain Ravaud, Christine Théodore, Claude Linassier, Sylvestre Le Moulec, Stéphane Culine, Sophie Abadie-Lacourtoisie, Armelle Caty, Emeline Levionnois, Marie-Christine Etienne-Grimaldi, Helena Pereira, Laure Fournier, Arnaud Mejean, Laetitia Mauge
Kaplan-Meier analysis of progression-free survival (PFS; A-D) and overall survival (OS; E-F) according to baseline biomarker levels. HR, hazard ratio; CI, confidence interval.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1d22d6857891b3cf4cf94bcd2a9763a
https://doi.org/10.1158/1078-0432.22469475.v1
https://doi.org/10.1158/1078-0432.22469475.v1
Autor:
Bernard Escudier, Laurent Guy, Arnaud Mejean, Thierry Lebret, Brigitte Laguerre, Laurence Albiges, Jean-Marc Tréluyer, Marine Gross-Goupil, Eric Lechevallier, Claude Linassier, Alain Ravaud, Karim Bensalah, Antoine Thiery-Vuillemin, Marc-Olivier Timsit, Stéphane Oudard, Lionnel Geoffrois, Frederic Rolland, Sandra Colas, Christine Chevreau, Simon Thezenas, Luc Cormier, Jean-Christophe Bernhard, Hervé Lang, Gwenaelle Gravis
Publikováno v:
European Urology
European Urology, 2021, 80 (4), pp.417-424. ⟨10.1016/j.eururo.2021.06.009⟩
European Urology, Elsevier, 2021, 80 (4), pp.417-424. ⟨10.1016/j.eururo.2021.06.009⟩
European Urology, 2021, 80 (4), pp.417-424. ⟨10.1016/j.eururo.2021.06.009⟩
European Urology, Elsevier, 2021, 80 (4), pp.417-424. ⟨10.1016/j.eururo.2021.06.009⟩
Background The CARMENA trial in patients with metastatic renal cell carcinoma (mRCC) demonstrated that treatment with sunitinib alone was noninferior to cytoreductive nephrectomy (CN) followed by sunitinib (nephrectomy⬜sunitinib). Objective The obj
Autor:
Lucía Carril-Ajuria, Emeline Colomba, Carmen Romero-Ferreiro, Luigi Cerbone, Raffaele Ratta, Philippe Barthelemy, Clarisse Vindry, Aude Fléchon, François Cherifi, Elouen Boughalem, Claude Linassier, Giuseppe Fornarini, Sara E. Rebuzzi, Marine Gross-Goupil, Carolina Saldana, Maricruz Martin-Soberón, Guillermo de Velasco, Ray Manneh, Cristina Pernaut, Ana Sanchez de Torre, Ronan Flippot, Bernard Escudier, Laurence Albiges
Publikováno v:
European journal of cancer (Oxford, England : 1990). 180
Background Immune checkpoint inhibitor-based combination therapy (ICI-based combination) is a new standard of care for metastatic clear cell renal cell carcinoma (mRCC) in the frontline setting. Patients with poor performance status (PS) (≥2) were
Autor:
Mylene Wespiser, Lucia Carril-Ajuria, Blazevic Ilfad, Constance Thibault, Aude Flechon, Sophie Martin, Mathieu Laramas, Delphine Borchiellini, Camille Simon, Hakim Mahammedi, Claude Linassier, Morgan Goujon, Sonia Zaibet, Frederic Rolland, Laurence Albiges, Aurelia Meurisse, Antoine Falcoz, Antoine Thiery-Vuillemin
Publikováno v:
Journal of Clinical Oncology. 41:618-618
618 Background: Muscle metastases (MM) are among rare secondary locations in renal cell carcinoma (RCC). Current guidelines do not provide specific advice on the management of these patients. There is a lack of scientific literature on the subject, m